BGIM
ALXN

Boussard & Gavaudan Investment Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Boussard & Gavaudan Investment Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-624,427
Closed -$115M – 158
2021
Q2 		$115M Sell
624,427
-83,948
-12% -$15.4M 10.9% 2
2021
Q1 		$109M Buy
+708,375
New +$109M 10.57% 2